Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy

Atherosclerosis

Volumn 162, Issue 2, 2002, Pages 315-321

  Choudhury, Robin P ^a   Gilberto Aguinaldo, J ^a   Rong, James X ^a   Kulak, Jessica L ^a   Kulak, Amy R ^a   Reis, Ernane D ^a   Fallon, John T ^a   Fuster, Valentin ^a   Fisher, Edward A ^a   Fayad, Zahi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aorta; Atherosclerosis; Magnetic resonance imaging; Plaque

Indexed keywords

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA WALL; ARTERY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GENETIC ENGINEERING; IN VIVO STUDY; MALE; MICROSCOPY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THICKNESS;

ANIMALS; AORTA, ABDOMINAL; AORTIC DISEASES; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0036233707     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00730-4     Document Type: Article

References (42)

1. Mouse models of atherosclerosis
2. The emergence of mouse models of atherosclerosis and their relevance to clinical research
3. Atherosclerosis and the mouse: A decade of experience
4. Learning from the transgenic mouse: Endothelium, adhesive molecules, and neointimal formation
5. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
6. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
7. Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium
8. Interleukin-6 exacerbates early atherosclerosis in mice
9. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice
10. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice
11. Complete atherosclerosis regression after human ApoE gene transfer in ApoE-deficient/nude mice
12. Imaging the murine cardiovascular system with magnetic resonance
13. Does therapeutic intervention achieve slowing of progression or bona fide regression of atherosclerotic lesions?
14. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
15. Peripheral vascular stenosis in apolipoprotein E-deficient mice. Potential roles of lipid deposition, medial atrophy, and adventitial inflammation
16. Hyperlipidemia and atherosclerotic lesion development in LDL receptor- deficient mice fed defined semipurified diets with and without cholate
17. A transplant model to study the long term effects of apolipoprotein AI expression in large complex lesions in ApoE deficient mice
18. Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice
19. Statistical methods for assessing agreement between two methods of clinical measurement
20. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging
21. MRI of rabbit atherosclerosis in response to dietary cholesterol lowering
22. Histology by magnetic resonance microscopy
23. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: A comparison with transesophageal echocardiography
24. High-resolution three-dimensional in vivo imaging of atherosclerotic plaque
25. Reduction of partial-volume artifacts with zero-filled interpolation in three-dimensional MR angiography
26. Angiographic progression of coronary artery disease and the development of myocardial infarction
27. Macrophages and atherosclerotic plaque stability
28. New insights into plaque stabilisation by lipid lowering
29. Characterization of atherosclerotic plaques by magnetic resonance imaging
30. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo
31. Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: An in vivo study in rabbits
32. In vivo 1H-NMR microimaging with respiratory triggering for monitoring adoptive immunotherapy of metastatic mouse lymphoma
33. Compensatory enlargement of human atherosclerotic coronary arteries
34. Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis
35. Arterial remodeling. Mechanisms and clinical implications
36. Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events
37. Types of change in coronary stenosis severity and their relative importance in overall progression and regression of coronary disease. Observations from the FATS Trial. Familial Atherosclerosis Treatment Study
38. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?
39. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease
40. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging
41. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
42. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)